SCHEMBL208541

SCHEMBL208541

CC(C)[Si](OC1CCC([C@@H](c2c(Cl)cc(-c3ccc(C(=O)O)cc3)cc2Cl)C2CCNC2=O)CC1)(C(C)C)C(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 3/20 0.32
PDE4D Q08499 2/20 0.32
PDE5A O76074 1/20 0.32
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE7A Q13946 1/20 0.32
PDE1C Q14123 1/20 0.32
PDE3A Q14432 1/20 0.32
RXRA P19793 2/20 0.32
RXRB P28702 2/20 0.32
TNKS2 Q9H2K2 1/20 0.32
AKR1C2 P52895 1/20 0.31
AKR1C1 Q04828 1/20 0.31
PRKAB2 O43741 1/20 0.31
PRKAG1 P54619 1/20 0.31
PRKAA2 P54646 1/20 0.31
PRKAA1 Q13131 1/20 0.31
PRKAG3 Q9UGI9 1/20 0.31
PRKAG2 Q9UGJ0 1/20 0.31
PRKAB1 Q9Y478 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4060990 1.00 SRD5A2 (0.32) SRD5A2PDE4DPDE5APDE1APDE1B
SCHEMBL207570 0.91 MAP2K4 (0.35) MAP2K4
SCHEMBL208452 0.88 PDE4D (0.35) SRD5A2PDE4DPDE5APDE1APDE1B
SCHEMBL209158 0.88 MEN1 (0.32) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL208778 0.88 MEN1 (0.32) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL1092157 0.85 PDE4D (0.32) SRD5A2PDE4DPDE5APDE1APDE1B
SCHEMBL209307 0.83 PDE4D (0.41) SRD5A2PDE4DPDE5APDE1APDE1B
SCHEMBL209090 0.82 XDH (0.33) AKR1C2AKR1C1PRKAB2PRKAG1PRKAA2
SCHEMBL474877 0.81 PDE5A (0.39) PDE4DPDE5APDE1APDE1BPDE7A
SCHEMBL3946179 0.81 PDE5A (0.39) PDE4DPDE5APDE1APDE1BPDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-7816349-B2 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-10-19 US disclosed
EP-2029529-B1 SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2010-07-07 EP disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
US-20090069326-A1 SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069326-A1 SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 SRD5A2 23/4885PDE4D 835/4885PDE5A 232/4885
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 SRD5A2 34/4885PDE4D 1270/4885PDE5A 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.